4
Changes in Ownership
BlossomHill Therapeutics, Inc. Filed Acc 0002143905-26-000003
General Counsel bought 4,700 shares at an average $15.89 ($74,700)
- General Counsel acquired 22,687 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Liptak Vincent Paul General Counsel | 2026-08-07 | Purchase | +2,500 | $15.80 | $39,500 | 109,212 | D: show line 1 in the form |
| Liptak Vincent Paul General Counsel | 2026-08-10 | Purchase | +2,200 | $16.00 | $35,200 | 111,412 | D: show line 2 in the form |
| Liptak Vincent Paul General Counsel | 2026-08-10 | Conversion | +22,687 | 22,687 | I: show line 3 in the form | ||
| Open-market purchases · 4,700 sh · avg $15.89 · $74,700 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Liptak Vincent Paul General Counsel | 2026-08-06 | Grant or award · Employee Stock Option (Right to Buy) | +46,561 | 46,561 | D: show line 4 in the form | ||
| Liptak Vincent Paul General Counsel | 2026-08-10 | Conversion · Series B Preferred Stock | −22,687 | 0 | I: show line 5 in the form |
Loading xslF345X06/form4-08102026_100801.xml…